Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Melanoma 2Advanced Malignant Solid Neoplasm 2Urinary Bladder Neoplasms 1Syndrome 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Inflammatory Bowel Diseases 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1HIV Infections 1Fatigue 1Endometrial Neoplasms 1Dyspnea 1Disease 1Crohn Disease 1Cough 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1

Interventions

Radiotherapy 5Oxaliplatin 5Nivolumab 5Fluorouracil 5Cetuximab 5Leucovorin 4Magnetic Resonance Spectroscopy 3Bevacizumab 3sintilimab 2pembrolizumab 2fludarabine 2encorafenib 2aldesleukin 2Tomography, X-Ray Computed 2Specimen Handling 2Pemetrexed 2Magnetic Resonance Imaging 2Irinotecan 2Gemcitabine 2Folfox protocol 2Electrocardiography 2Drug Therapy 2Dexamethasone 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Educational Status × 30 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡